Biomerica announces the SFDA approved its at home PSA screening test

Biomerica announces that the Saudi Food and Drug Authority, SFDA, has approved the Company’s Fortel Prostate, PSA, Screening Test to be sold and used in the country. This at-home test is designed to empower men with the ability to detect early warning signs of prostate cancer from the comfort of their own homes. This approval marks a milestone in Biomerica’s strategic expansion into the Middle East, a region where prostate cancer is increasingly recognized as a public health concern.